Artivion (AORT) Net Cash Flow (2010 - 2026)
Artivion (AORT) posted Net Cash Flow of -$8.9 million for Q1 2026, down 4.33% on a QoQ basis from -$8.5 million in Q4 2025, and up 46.64% year-over-year from -$6.1 million in Q1 2025.
Artivion (AORT) Net Cash Flow (2010 - 2026) Analysis & Trends
Artivion's Net Cash Flow history runs 17 years deep, the most recent figure standing at -$8.9 million for Q1 2026.
- Quarterly Net Cash Flow rose 46.64% year-over-year to -$8.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.9 million (up 240.32% YoY) and the FY2025 annual result came in at $9.1 million, up 343.29% from the prior year.
- Net Cash Flow was -$8.9 million for Q1 2026 at Artivion, down from -$8.5 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $20.0 million in Q3 2025 and bottomed at -$16.7 million in Q1 2025.
- A 5-year average of -$107823.5 and a median of -$1.1 million in 2024 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 772.43% in 2025, while the deepest fall reached 665.92% in 2025.
- Artivion's Net Cash Flow stood at -$3.7 million in 2022, then surged by 274.65% to $6.5 million in 2023, then plunged by 117.01% to -$1.1 million in 2024, then sank by 665.92% to -$8.5 million in 2025, then decreased by 4.33% to -$8.9 million in 2026.
- Business Quant data shows AORT's Net Cash Flow at -$8.9 million in Q1 2026, -$8.5 million in Q4 2025, and $20.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Artivion | 1.25 Bn | 1.19 Bn | 75.45 Mn | -8.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.89 Mn |
| Mar 31, 2026 | -8.89 Mn |
| Dec 31, 2025 | -8.52 Mn |
| Dec 31, 2025 | -8.52 Mn |
| Sep 30, 2025 | 19.97 Mn |
| Sep 30, 2025 | 19.97 Mn |
| Jun 30, 2025 | 14.32 Mn |
| Jun 30, 2025 | 14.32 Mn |
| Mar 31, 2025 | -16.65 Mn |
| Mar 31, 2025 | -16.65 Mn |
| Dec 31, 2024 | -1.11 Mn |
| Dec 31, 2024 | -1.11 Mn |
| Sep 30, 2024 | 2.29 Mn |
| Sep 30, 2024 | 2.29 Mn |
| Jun 30, 2024 | 3.44 Mn |
| Jun 30, 2024 | 3.44 Mn |
| Mar 31, 2024 | -8.37 Mn |
| Mar 31, 2024 | -8.37 Mn |
| Dec 31, 2023 | 6.54 Mn |
| Dec 31, 2023 | 6.54 Mn |